NADPH oxidases: New actors in thyroid cancer?

Nature Reviews Endocrinology

Volumn 12, Issue 8, 2016, Pages 485-494

  Ameziane El Hassani, Rabii ^a,b   Schlumberger, Martin ^a,c   Dupuy, Corinne ^a,c  

^a Gustave Roussy Comprehensive Cancer Institute   (France)

^b CENTRE NATIONAL DE L ENERGIE DES SCIENCES TECHNIQUES NUCLEAIRES   (Morocco)

^c UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DUAL OXIDASE; OXIDOREDUCTASE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; TUMOR MARKER; UNCLASSIFIED DRUG; HYDROGEN PEROXIDE; IODIDE PEROXIDASE;

CARCINOGENESIS; CONGENITAL HYPOTHYROIDISM; ENZYME LOCALIZATION; ENZYME STRUCTURE; HUMAN; INFLAMMATORY DISEASE; IONIZING RADIATION; META ANALYSIS (TOPIC); MOLECULAR PATHOLOGY; NONHUMAN; ONCOGENE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; RADIATION CARCINOGENESIS; REVIEW; THYROID CANCER; THYROID DISEASE; THYROID INFLAMMATORY DISEASE; DNA DAMAGE; ENZYMOLOGY; METABOLISM; PATHOPHYSIOLOGY; RISK FACTOR; ROLE PLAYING; SENSITIVITY AND SPECIFICITY; THYROID GLAND; THYROID NEOPLASMS;

CARCINOGENESIS; DNA DAMAGE; HUMANS; HYDROGEN PEROXIDE; IODIDE PEROXIDASE; NADPH OXIDASE; RISK FACTORS; ROLE; SENSITIVITY AND SPECIFICITY; THYROID GLAND; THYROID NEOPLASMS;

EID: 84968626434     PISSN: 17595029     EISSN: 17595037     Source Type: Journal    
DOI: 10.1038/nrendo.2016.64     Document Type: Review

References (125)

1. Ekholm, R. Iodination of thyroglobulin: an intracellular or extracellular process? Mol. Cell. Endocrinol. 24, 141-163 (1981).
2. Dupuy, C. et al. Purification of a novel flavoprotein involved in the thyroid NADPH oxidase. Cloning of the porcine and human cDNAs. J. Biol. Chem. 274, 37265-37269 (1999).
3. De Deken, X. et al. Cloning of two human thyroid cDNAs encoding new members of the NADPH oxidase family. J. Biol. Chem. 275, 23227-23233 (2000).
4. Weyemi, U. et al. Intracellular expression of reactive oxygen species-generating NADPH oxidase NOX4 in normal and cancer thyroid tissues. Endocr. Relat. Cancer 17, 27-37 (2010).
5. Sumimoto, H. Structure, regulation and evolution of Nox-family NADPH oxidases that produce reactive oxygen species. FEBS J. 275, 3249-3277 (2008).
6. Lambeth, J. D. NOX enzymes and the biology of reactive oxygen. Nat. Rev. Immunol. 4, 181-189 (2004).
7. De Deken, X., Corvilain, B., Dumont, J. E., Miot, F. Roles of DUOX-mediated hydrogen peroxide in metabolism, host defense, and signaling. Antioxid. Redox Signal. 20, 2776-2793 (2014).
8. Bedard, K., Krause, K. H. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol. Rev. 87, 245-313 (2007).
9. Macheret, M., Halazonetis, T. D. DNA replication stress as a hallmark of cancer. Annu. Rev. Pathol. 10, 425-448 (2015).
10. Maier, J. et al. Deoxyribonucleic acid damage and spontaneous mutagenesis in the thyroid gland of rats and mice. Endocrinology 147, 3391-3397 (2006).
11. Krohn, K., Maier, J., Paschke, R. Mechanisms of disease: hydrogen peroxide, DNA damage and mutagenesis in the development of thyroid tumors. Nat. Clin. Pract. Endocrinol. Metab. 3, 713-720 (2007).
12. Vizioli, M. G. et al. Evidence of oncogene-induced senescence in thyroid carcinogenesis. Endocr. Relat. Cancer 18, 743-757 (2011).
13. Nakashima, M. et al. Foci formation of P53-binding protein 1 in thyroid tumors: activation of genomic instability during thyroid carcinogenesis. Int. J. Cancer 122, 1082-1088 (2008).
14. Mussazhanova, Z. et al. Significance of p53-binding protein 1 (53BP1) expression in thyroid papillary microcarcinoma: association with BRAFV600E mutation status. Histopathology 63, 726-734 (2013).
15. Weyemi, U. et al. ROS-generating NADPH oxidase NOX4 is a critical mediator in oncogenic H-Ras-induced DNA damage and subsequent senescence. Oncogene 31, 1117-1129 (2012).
16. Ameziane-El-Hassani, R. et al. NADPH oxidase DUOX1 promotes long-term persistence of oxidative stress after an exposure to irradiation. Proc. Natl Acad. Sci. USA 112, 5051-5056 (2015).
17. Lukosz, M. et al. Nuclear redox signaling. Antioxid. Redox Signal. 12, 713-742 (2010).
18. Veal, E. A., Day, A. M., Morgan, B. A. Hydrogen peroxide sensing and signaling. Mol. Cell 26, 1-14 (2007).
19. Miller, E. W., Dickinson, B. C., Chang, C. J. Aquaporin-3 mediates hydrogen peroxide uptake to regulate downstream intracellular signaling. Proc. Natl Acad. Sci. USA 107, 15681-15686 (2010).
20. Burdon, R. H., Alliangana, D., Gill, V. Hydrogen peroxide and the proliferation of BHK-21 cells. Free Radic. Res. 23, 471-486 (1995).
21. Meng, T. C., Fukada, T., Tonks, N. K. Reversible oxidation and inactivation of protein tyrosine phosphatases in vivo. Mol. Cell 9, 387-399 (2002).
22. Boivin, B., Zhang, S., Arbiser, J. L., Zhang, Z. Y., Tonks, N. K. A modified cysteinyl-labeling assay reveals reversible oxidation of protein tyrosine phosphatases in angiomyolipoma cells. Proc. Natl Acad. Sci. USA 105, 9959-9964 (2008).
23. Xanthoudakis, S., Curran, T. Identification and characterization of Ref-1, a nuclear protein that facilitates AP-1 DNA-binding activity. EMBO J. 11, 653-665 (1992).
24. Verrastro, I., Tveen-Jensen, K., Woscholski, R., Spickett, C. M., Pitt, A. R. Reversible oxidation of phosphatase and tensin homolog (PTEN) alters its interactions with signaling and regulatory proteins. Free Radic. Biol. Med. 90, 24-34 (2015).
25. Hainaut, P., Milner, J. Redox modulation of p53 conformation and sequence-specific DNA binding in vitro. Cancer Res. 53, 4469-4473 (1993).
26. Abate, C., Patel, L., Rauscher, F. J., 3rd & Curran, T. Redox regulation of fos and jun DNA-binding activity in vitro. Science 249, 1157-1161 (1990).
27. Segal, A. W. Absence of both cytochrome b-245 subunits from neutrophils in X-linked chronic granulomatous disease. Nature 326, 88-91 (1987).
28. Parkos, C. A., Dinauer, M. C., Jesaitis, A. J., Orkin, S. H., Curnutte, J. T. Absence of both the 91kD and 22kD subunits of human neutrophil cytochrome b in two genetic forms of chronic granulomatous disease. Blood 73, 1416-1420 (1989).
29. Lipinski, S. et al. DUOX2-derived reactive oxygen species are effectors of NOD2-mediated antibacterial responses. J. Cell Sci. 122, 3522-3530 (2009).
30. Kumar, S., Molina-Cruz, A., Gupta, L., Rodrigues, J., Barillas-Mury, C. A peroxidase/dual oxidase system modulates midgut epithelial immunity in Anopheles gambiae. Science 327, 1644-1648 (2010).
31. Koff, J. L., Shao, M. X., Kim, S., Ueki, I. F., Nadel, J. A. Pseudomonas lipopolysaccharide accelerates wound repair via activation of a novel epithelial cell signaling cascade. J. Immunol. 177, 8693-8700 (2006).
32. Geiszt, M., Witta, J., Baffi, J., Lekstrom, K., Leto, T. L. Dual oxidases represent novel hydrogen peroxide sources supporting mucosal surface host defense. FASEB J. 17, 1502-1504 (2003).
33. Boots, A. W. et al. ATP-mediated activation of the NADPH oxidase DUOX1 mediates airway epithelial responses to bacterial stimuli. J. Biol. Chem. 284, 17858-17867 (2009).
34. Szatrowski, T. P., Nathan, C. F. Production of large amounts of hydrogen peroxide by human tumor cells. Cancer Res. 51, 794-798 (1991).
35. Aykin-Burns, N., Ahmad, I. M., Zhu, Y., Oberley, L. W., Spitz, D. R. Increased levels of superoxide and H2O2 mediate the differential susceptibility of cancer cells versus normal cells to glucose deprivation. Biochem. J. 418, 29-37 (2009).
36. Bartkova, J. et al. DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature 434, 864-870 (2005).
37. Leusen, J. H. et al. A point mutation in gp91-phox of cytochrome b558 of the human NADPH oxidase leading to defective translocation of the cytosolic proteins p47-phox and p67-phox. J. Clin. Invest. 93, 2120-2126 (1994).
38. Grasberger, H., Refetoff, S. Identification of the maturation factor for dual oxidase. Evolution of an eukaryotic operon equivalent. J. Biol. Chem. 281, 18269-18272 (2006).
39. Pachucki, J., Wang, D., Christophe, D., Miot, F. Structural and functional characterization of the two human ThOX/Duox genes and their 5?-flanking regions. Mol. Cell. Endocrinol. 214, 53-62 (2004).
40. El Hassani, R. A. et al. Dual oxidase2 is expressed all along the digestive tract. Am. J. Physiol. Gastrointest. Liver Physiol. 288, G933-G942 (2005).
41. Luxen, S. et al. Heterodimerization controls localization of Duox-DuoxA NADPH oxidases in airway cells. J. Cell Sci. 122, 1238-1247 (2009).
42. Morand, S. et al. Duox maturation factors form cell surface complexes with Duox affecting the specificity of reactive oxygen species generation. FASEB J. 23, 1205-1218 (2009).
43. Xu, C., Linderholm, A., Grasberger, H., Harper, R. W. Dual oxidase 2 bidirectional promoter polymorphisms confer differential immune responses in airway epithelia. Am. J. Respir. Cell. Mol. Biol. 47, 484-490 (2012).
44. Ameziane-El-Hassani, R. et al. Dual oxidase-2 has an intrinsic Ca2+dependent H2O2-generating activity. J. Biol. Chem. 280, 30046-30054 (2005).
45. Ueyama, T. et al. The extracellular A-loop of dual oxidases affects the specificity of reactive oxygen species release. J. Biol. Chem. 290, 6495-6506 (2015).
46. Meitzler, J. L., Hinde, S., Banfi, B., Nauseef, W. M., Ortiz de Montellano, P. R. Conserved cysteine residues provide a protein-protein interaction surface in dual oxidase (DUOX) proteins. J. Biol. Chem. 288, 7147-7157 (2013).
47. Fortunato, R. S. et al. Functional consequences of dual oxidase-thyroperoxidase interaction at the plasma membrane. J. Clin. Endocrinol. Metab. 95, 5403-5411 (2010).
48. Carre, A. et al. When an intramolecular disulfide bridge governs the interaction of DUOX2 with its partner DUOXA2. Antioxid. Redox Signal. 23, 724-733 (2015).
49. Song, Y. et al. Association of duoxes with thyroid peroxidase and its regulation in thyrocytes. J. Clin. Endocrinol. Metab. 95, 375-382 (2010).
50. Rigutto, S. et al. Activation of dual oxidases Duox1 and Duox2: differential regulation mediated by camp-dependent protein kinase and protein kinase C-dependent phosphorylation. J. Biol. Chem. 284, 6725-6734 (2009).
51. Allgeier, A. et al. The human thyrotropin receptor activates G-proteins Gs and Gq/11. J. Biol. Chem. 269, 13733-13735 (1994).
52. Knobel, M., Medeiros-Neto, G. An outline of inherited disorders of the thyroid hormone generating system. Thyroid 13, 771-801 (2003).
53. Laurent, E. et al. Unlike thyrotropin, thyroid-stimulating antibodies do not activate phospholipase C in human thyroid slices. J. Clin. Invest. 87, 1634-1642 (1991).
54. Ledent, C., Dumont, J. E., Vassart, G., Parmentier, M. Thyroid expression of an A2 adenosine receptor transgene induces thyroid hyperplasia and hyperthyroidism. EMBO J. 11, 537-542 (1992).
55. Ledent, C. et al. Costimulation of adenylyl cyclase and phospholipase C by a mutant ? 1B-adrenergic receptor transgene promotes malignant transformation of thyroid follicular cells. Endocrinology 138, 369-378 (1997).
56. Fragu, P., Nataf, B. M. Human thyroid peroxidase activity in benign and malign thyroid disorders. J. Clin. Endocrinol. Metab. 45, 1089-1096 (1977).
57. Cardoso, L. C. et al. Ca2 adenine dinucleotide phosphate-dependent H2O2 generation is inhibited by iodide in human thyroids. J. Clin. Endocrinol. Metab. 86, 4339-4343 (2001).
58. Corvilain, B., Collyn, L., van Sande, J., Dumont, J. E. Stimulation by iodide of H2O2 generation in thyroid slices from several species. Am. J. Physiol. Endocrinol. Metab. 278, E692-E699 (2000).
59. Morand, S. et al. Effect of iodide on nicotinamide adenine dinucleotide phosphate oxidase activity and Duox2 protein expression in isolated porcine thyroid follicles. Endocrinology 144, 1241-1248 (2003).
60. Ambasta, R. K. et al. Direct interaction of the novel Nox proteins with p22phox is required for the formation of a functionally active NADPH oxidase. J. Biol. Chem. 279, 45935-45941 (2004).
61. Lyle, A. N. et al. Poldip2, a novel regulator of Nox4 and cytoskeletal integrity in vascular smooth muscle cells. Circ. Res. 105, 249-259 (2009).
62. Sedeek, M., Hebert, R. L., Kennedy, C. R., Burns, K. D., Touyz, R. M. Molecular mechanisms of hypertension: role of Nox family NADPH oxidases. Curr. Opin. Nephrol. Hypertens. 18, 122-127 (2009).
63. Gorin, Y. et al. Nox4 mediates angiotensin II-induced activation of Akt/protein kinase B in mesangial cells. Am. J. Physiol. Renal Physiol. 285, F219-F229 (2003).
64. Takac, I. et al. The E-loop is involved in hydrogen peroxide formation by the NADPH oxidase Nox4. J. Biol. Chem. 286, 13304-13313 (2011).
65. Block, K., Gorin, Y., Abboud, H. E. Subcellular localization of Nox4 and regulation in diabetes. Proc. Natl Acad. Sci. USA 106, 14385-14390 (2009).
66. Lee, W. J. et al. N?-carboxymethyllysine-mediated endoplasmic reticulum stress promotes endothelial cell injury through Nox4/MKP-3 interaction. Free Radic. Biol. Med. 74, 294-306 (2014).
67. Spencer, N. Y. et al. Control of hepatic nuclear superoxide production by glucose 6-phosphate dehydrogenase and NADPH oxidase-4. J. Biol. Chem. 286, 8977-8987 (2011).
68. Szinnai, G. Clinical genetics of congenital hypothyroidism. Endocr. Dev. 26, 60-78 (2014).
69. Moreno, J. C. et al. Inactivating mutations in the gene for thyroid oxidase 2 (THOX2) and congenital hypothyroidism. N. Engl. J. Med. 347, 95-102 (2002).
70. Narumi, S., Muroya, K., Asakura, Y., Aachi, M., Hasegawa, T. Molecular basis of thyroid dyshormonogenesis: genetic screening in population-based Japanese patients. J. Clin. Endocrinol. Metab. 96, E1838-E1842 (2011).
71. Zamproni, I. et al. Biallelic inactivation of the dual oxidase maturation factor 2 (DUOXA2) gene as a novel cause of congenital hypothyroidism. J. Clin. Endocrinol. Metab. 93, 605-610 (2008).
72. Donko, A. et al. Urothelial cells produce hydrogen peroxide through the activation of Duox1. Free Radic. Biol. Med. 49, 2040-2048 (2010).
73. Johnson, K. R. et al. Congenital hypothyroidism, dwarfism, and hearing impairment caused by a missense mutation in the mouse dual oxidase 2 gene, Duox2. Mol. Endocrinol. 21, 1593-1602 (2007).
74. Grasberger, H. et al. Mice deficient in dual oxidase maturation factors are severely hypothyroid. Mol. Endocrinol. 26, 481-492 (2012).
75. Duthoit, C. et al. Hydrogen peroxide-induced production of a 40 kDa immunoreactive thyroglobulin fragment in human thyroid cells: the onset of thyroid autoimmunity? Biochem. J. 360, 557-562 (2001).
76. El Hassani, R. A. et al. Antigenicity and immunogenicity of the C-terminal peptide of human thyroglobulin. Peptides 25, 1021-1029 (2004).
77. Gerard, A. C., Many, M. C., Daumerie, C., Knoops, B., Colin, I. M. Peroxiredoxin 5 expression in the human thyroid gland. Thyroid 15, 205-209 (2005).
78. Poncin, S. et al. N-acetylcysteine and 15 deoxy-?12,14-prostaglandin J2 exert a protective effect against autoimmune thyroid destruction in vivo but not against interleukin-1?/interferon ?-induced inhibitory effects in thyrocytes in vitro. Am. J. Pathol. 177, 219-228 (2010).
79. Raad, H., Eskalli, Z., Corvilain, B., Miot, F., De Deken, X. Thyroid hydrogen peroxide production is enhanced by the Th2 cytokines, IL-4 and IL-13, through increased expression of the dual oxidase 2 and its maturation factor DUOXA2. Free Radic. Biol. Med. 56, 216-225 (2013).
80. Marique, L. et al. The expression of dual oxidase, thyroid peroxidase, and caveolin-1 differs according to the type of immune response (TH1/TH2) involved in thyroid autoimmune disorders. J. Clin. Endocrinol. Metab. 99, 1722-1732 (2014).
81. Colotta, F., Allavena, P., Sica, A., Garlanda, C., Mantovani, A. Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis 30, 1073-1081 (2009).
82. Guarino, V., Castellone, M. D., Avilla, E., Melillo, R. M. Thyroid cancer and inflammation. Mol. Cell. Endocrinol. 321, 94-102 (2010).
83. Rhoden, K. J. et al. RET/papillary thyroid cancer rearrangement in nonneoplastic thyrocytes: follicular cells of Hashimoto's thyroiditis share low-level recombination events with a subset of papillary carcinoma. J. Clin. Endocrinol. Metab. 91, 2414-2423 (2006).
84. Nikiforov, Y. E., Nikiforova, M. N. Molecular genetics and diagnosis of thyroid cancer. Nat. Rev. Endocrinol. 7, 569-580 (2011).
85. Ameziane-El-Hassani, R. et al. Role of H2O2 in RET/PTC1 chromosomal rearrangement produced by ionizing radiation in human thyroid cells. Cancer Res. 70, 4123-4132 (2010).
86. Driessens, N. et al. Hydrogen peroxide induces DNA single-and double-strand breaks in thyroid cells and is therefore a potential mutagen for this organ. Endocr. Relat. Cancer 16, 845-856 (2009).
87. Sedelnikova, O. A. et al. Role of oxidatively induced DNA lesions in human pathogenesis. Mutat. Res. 704, 152-159 (2010).
88. Karger, S. et al. Distinct pattern of oxidative DNA damage and DNA repair in follicular thyroid tumours. J. Mol. Endocrinol. 48, 193-202 (2012).
89. Cancer Genome Atlas Research, N. Integrated genomic characterization of papillary thyroid carcinoma. Cell 159, 676-690 (2014).
90. Li, C., Xiang, X., Zhou, Y. No association between XRCC1 genetic polymorphisms and differentiated thyroid carcinoma risk: a meta-analysis. Mol. Biol. Rep. 41, 7613-7621 (2014).
91. Wang, C., Ai, Z. Association of XRCC1 polymorphisms with thyroid cancer risk. Tumour Biol. 35, 4791-4797 (2014).
92. Berquist, B. R., Wilson, D. M. 3rd Pathways for repairing and tolerating the spectrum of oxidative DNA lesions. Cancer Lett. 327, 61-72 (2012).
93. Richardson, C., Jasin, M. Frequent chromosomal translocations induced by DNA double-strand breaks. Nature 405, 697-700 (2000).
94. Viglietto, G. et al. RET/PTC oncogene activation is an early event in thyroid carcinogenesis. Oncogene 11, 1207-1210 (1995).
95. Versteyhe, S. et al. Comparative analysis of the thyrocytes and T cells: responses to H2O2 and radiation reveals an H2O2-induced antioxidant transcriptional program in thyrocytes. J. Clin. Endocrinol. Metab. 98, E1645-E1654 (2013).
96. Bhatia, S., Sklar, C. Second cancers in survivors of childhood cancer. Nat. Rev. Cancer 2, 124-132 (2002).
97. Schneider, A. B., Sarne, D. H. Long-term risks for thyroid cancer and other neoplasms after exposure to radiation. Nat. Clin. Pract. Endocrinol. Metab. 1, 82-91 (2005).
98. Azzam, E. I., Jay-Gerin, J. P., Pain, D. Ionizing radiation-induced metabolic oxidative stress and prolonged cell injury. Cancer Lett. 327, 48-60 (2012).
99. Roy, K., Kodama, S., Suzuki, K., Fukase, K., Watanabe, M. Hypoxia relieves X-ray-induced delayed effects in normal human embryo cells. Radiat. Res. 154, 659-666 (2000).
100. Suzuki, K., Ojima, M., Kodama, S., Watanabe, M. Radiation-induced DNA damage and delayed induced genomic instability. Oncogene 22, 6988-6993 (2003).
101. Lorimore, S. A., Coates, P. J., Wright, E. G. Radiation-induced genomic instability and bystander effects: inter-related nontargeted effects of exposure to ionizing radiation. Oncogene 22, 7058-7069 (2003).
102. Cleaver, J. E. et al. Mitochondrial reactive oxygen species are scavenged by Cockayne syndrome B protein in human fibroblasts without nuclear DNA damage. Proc. Natl Acad. Sci. USA 111, 13487-13492 (2014).
103. Strengert, M. et al. Mucosal reactive oxygen species are required for antiviral response: role of Duox in influenza a virus infection. Antioxid. Redox Signal. 20, 2695-2709 (2014).
104. Detours, V. et al. Genome-wide gene expression profiling suggests distinct radiation susceptibilities in sporadic and post-Chernobyl papillary thyroid cancers. Br. J. Cancer 97, 818-825 (2007).
105. Dom, G. et al. A gene expression signature distinguishes normal tissues of sporadic and radiation-induced papillary thyroid carcinomas. Br. J. Cancer 107, 994-1000 (2012).
106. Lacroix, L. et al. Expression of nicotinamide adenine dinucleotide phosphate oxidase flavoprotein DUOX genes and proteins in human papillary and follicular thyroid carcinomas. Thyroid 11, 1017-1023 (2001).
107. Ling, Q. et al. Epigenetic silencing of dual oxidase 1 by promoter hypermethylation in human hepatocellular carcinoma. Am. J. Cancer Res. 4, 508-517 (2014).
108. Luxen, S., Belinsky, S. A., Knaus, U. G. Silencing of DUOX NADPH oxidases by promoter hypermethylation in lung cancer. Cancer Res. 68, 1037-1045 (2008).
109. Wu, Y. et al. Functional activity and tumor-specific expression of dual oxidase 2 in pancreatic cancer cells and human malignancies characterized with a novel monoclonal antibody. Int. J. Oncol. 42, 1229-1238 (2013).
110. Ramsey, M. R., Sharpless, N. E. ROS as a tumour suppressor? Nat. Cell Biol. 8, 1213-1215 (2006).
111. Bartkova, J. et al. Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints. Nature 444, 633-637 (2006).
112. Lee, A. C. et al. Ras proteins induce senescence by altering the intracellular levels of reactive oxygen species. J. Biol. Chem. 274, 7936-7940 (1999).
113. Vafa, O. et al. c-Myc can induce DNA damage, increase reactive oxygen species, and mitigate p53 function: a mechanism for oncogene-induced genetic instability. Mol. Cell 9, 1031-1044 (2002).
114. Zeman, M. K., Cimprich, K. A. Causes and consequences of replication stress. Nat. Cell Biol. 16, 2-9 (2014).
115. Ogrunc, M. et al. Oncogene-induced reactive oxygen species fuel hyperproliferation and DNA damage response activation. Cell Death Differ. 21, 998-1012 (2014).
116. Xu, B. et al. Oxidative stress preferentially induces a subtype of micronuclei and mediates the genomic instability caused by p53 dysfunction. Mutat. Res. 770, 1-8 (2014).
117. Mishra, P. K. et al. Mitochondrial oxidative stress-induced epigenetic modifications in pancreatic epithelial cells. Int. J. Toxicol. 33, 116-129 (2014).
118. O'Hagan, H. M. et al. Oxidative damage targets complexes containing DNA methyltransferases, SIRT1, and polycomb members to promoter CpG Islands. Cancer Cell 20, 606-619 (2011).
119. Miot, F., Dupuy, C., Dumont, J., Rousset, B. Endotext Ch.2 (eds Groot, L. J. et al.) (South Dartmouth, 2000)
120. Hara-Chikuma, M. et al. Aquaporin-3-mediated hydrogen peroxide transport is required for NF-?B signalling in keratinocytes and development of psoriasis. Nat. Commun. 6, 7454 (2015).
121. Aird, K. M. et al. Suppression of nucleotide metabolism underlies the establishment and maintenance of oncogene-induced senescence. Cell Rep. 3, 1252-1265 (2013).
122. Bester, A. C. et al. Nucleotide deficiency promotes genomic instability in early stages of cancer development. Cell 145, 435-446 (2011).
123. Graindorge, D. et al. Singlet oxygen-mediated oxidation during UVA radiation alters the dynamic of genomic DNA replication. PLoS ONE 10, e0140645 (2015).
124. Gandhi, M., Dillon, L. W., Pramanik, S., Nikiforov, Y. E., Wang, Y. H. DNA breaks at fragile sites generate oncogenic RET/PTC rearrangements in human thyroid cells. Oncogene 29, 2272-2280 (2010).
125. Hirakawa, S., Saito, R., Ohara, H., Okuyama, R., Aiba, S. Dual oxidase 1 induced by Th2 cytokines promotes STAT6 phosphorylation via oxidative inactivation of protein tyrosine phosphatase 1B in human epidermal keratinocytes. J. Immunol. 186, 4762-4770 (2011).